A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer

Immunotherapy has become integral in cancer therapeutics over the past two decades and is now part of standard-of-care treatment in multiple cancer types. While various biomarkers and pathway alterations such as dMMR, CDK12, and AR-V7 have been identified in advanced prostate cancer to predict immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Sooi, Kenneth, Walsh, Robert, Kumarakulasinghe, Nesaretnam, Wong, Alvin, Ngoi, Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571060/
https://www.ncbi.nlm.nih.gov/pubmed/37842236
http://dx.doi.org/10.20517/cdr.2023.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571060/
https://www.ncbi.nlm.nih.gov/pubmed/37842236
http://dx.doi.org/10.20517/cdr.2023.48

Ejemplares similares